Science
Mechanism of Action
As a derivative of Retinyl Acetate, RETINYL METHOXY PEG-22 ACETATE is anticipated to act as a retinoid, undergoing conversion in the skin to retinoic acid, the biologically active form of vitamin A. Retinoic acid primarily exerts its molecular effects by binding to and activating retinoid nuclear receptors (RAR and RXR). This activation leads to alterations in gene expression and messenger RNA (mRNA) synthesis, thereby influencing cell differentiation, proliferation, and various other essential cellular functions.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
As a retinoid derivative, stability is a critical consideration. This ingredient and its relatives are sensitive to environmental factors such as light, oxygen, metal ions, elevated temperatures, and low pH, which can instigate degradation through isomerization and oxidation. Formulations in PEG solutions generally exhibit enhanced stability when stored frozen (-20°C) or refrigerated (4°C), protected from light exposure, and within containers purged of oxygen.
Safety
Safety Profile
Specific safety evaluations by the CIR Expert Panel or SCCS for RETINYL METHOXY PEG-22 ACETATE are not available. However, its foundational component, Retinyl Acetate, was reviewed by the CIR Expert Panel and deemed safe for cosmetic use at established concentrations in 1987, a conclusion reaffirmed in 2005. The SCCS opinion on Vitamin A (Retinol, Retinyl Acetate, Retinyl Palmitate) indicates safety in cosmetics at 0.05% Retinol Equivalent (RE) for body lotions and 0.3% RE for other leave-on and rinse-off products. The FDA classifies Retinyl Acetate as Generally Recognized As Safe (GRAS) for direct food additives, but data for its general recognition of safety and effectiveness as an active ingredient in OTC drugs is considered inadequate. PubChem lists Retinyl Acetate as an irritant.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While this ingredient functions as a retinoid derivative expected to deliver vitamin A benefits, specific safety and clinical efficacy data for RETINYL METHOXY PEG-22 ACETATE are currently insufficient for a comprehensive assessment.
Related
Similar Ingredients
Finding similar ingredients…